Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib

AÇIKALIN A., BAĞIR KILIÇ E., PAYDAŞ S., ALSANCAK P., ERGİN M.

CUKUROVA MEDICAL JOURNAL, vol.44, no.2, pp.395-401, 2019 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 2
  • Publication Date: 2019
  • Doi Number: 10.17826/cumj.442276
  • Journal Name: CUKUROVA MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.395-401
  • Çukurova University Affiliated: Yes

Abstract

Purpose: Multiple myeloma is a heterogeneous disease, for which an understanding of the prognostic and predictive value of chromosomal aberrations is necessary to prescribe the most appropriate therapy. We aimed to document the frequencies of chromosomal aberrations in our institute and searched the relationships between therapy regimens and chromosomal aberrations.